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IINTRODUCTION
A lesson learned from modern developmental biology is
the striking degree of conservation of strategies and mol-
ecules used to program developmental events in species as
diverse as insects, birds, amphibians, and mammals. None-
theless, mammals retain distinctions with regard to the
strategies used to protect and nourish their offspring during
development, namely the processes of implantation and
placentation. While involving relatively few cell types,
placentation is a complex process. Furthermore, genes as-
sociated with this process display remarkably high sponta-
neous mutational rates, suggesting a strong adaptive/
selection pressure on this tissue (Roberts et al., 1999). In the
ase of implantation, a highly coordinated process is set
nto motion whereby specialized cells of the embryo, the
rophectoderm and trophoblast, establish contact with a
pecialized tissue of the mother, the uterus. The exquisite
oordination involves the regulated production of growth
actors, cytokines, and hormones by embryonic as well as
aternal tissues of both uterine and extrauterine origins. In
oncert, complementary receptors for these factors must be
xpressed by the appropriate tissues to propagate implanta-
ion signals. In addition, cell surface components must
ecome functionally available to support attachment of
rophectoderm/trophoblast and uterine cells. To add to the
hallenge, it has been shown that, in most mammals, there
s only a restricted time during the uterine cycle during
hich implantation can occur (Psychoyos, 1986). Failure to
Dedicated to the memory of Loren Hoffman.
1 To whom correspondence should be addressed. E-mail:ccarson@udel.edu.
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All rights of reproduction in any form reserved.nitiate the critical early events of implantation during this
window of receptivity” results in early pregnancy failure.
In addition to processes occurring in the embryo during
he pre- and peri-implantation period, uterine events also
ay be considered in a developmental context. The uterus
ndergoes dynamic changes during the cycle and displays
any features typical of developmental processes, includ-
ng differential and ordered activation or repression of gene
xpression and programmed changes in posttranscriptional
nd posttranslational modifications of mRNA and proteins.
hile the progression of these events is largely driven by
ndocrine actions, they display the same sequential nature
s classical developmental processes. In the absence of an
mbryo, the uterus will progress through a predictable
eries of stages ultimately terminating in tissue regression
nd apoptosis. In the presence of an embryo, the endome-
rium not only is maintained, but also progresses through
n additional program of events, i.e., the decidual cell
esponse, leading to prolonged maintenance and additional
rograms of gene expression that otherwise are not ob-
erved (Parr and Parr, 1989). Thus, multipotentiality is
isplayed by uterine tissue.
From the above, it is apparent that, even though embry-
nic development may proceed normally, there remain
any opportunities for implantation failure. In this regard,
hile marked improvements in in vitro fertilization and
mbryo culture techniques have been made over the past 20
ears, pregnancy success rates following these procedures
ave improved only marginally (ASRM Report, 1999). This
as led to the proposition that additional uterine factors,
ritical for the implantation process, must be limiting.
dentification of such parameters could lead to tests used in
onjunction with available serum and histological assays to
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218 Carson et al.determine if the physiological state of the uterus is appro-
priate for embryo transfer. In addition, it is possible that
genetic or epigenetic differences between individuals may
impact the ability of the uterus to develop to a functionally
receptive state. Such individuals would not be good candi-
dates for embryo transfer, under any conditions. Other,
more subtle, problems may occur as well. For instance,
factors that significantly accelerate or delay the transition
to the receptive state would disrupt the normal coordina-
tion between embryonic and uterine development even
though all molecular players seem otherwise normal. In the
discussion below, we will present the current understand-
ing of the events of implantation in various model systems
and humans, primarily focusing on uterine developments.
In addition, information on a number of genes and gene
products that appear to play a role in the implantation
process in multiple species systems also will be presented.
BLASTOCYST/TROPHOBLAST EVENTS
The preimplantation stage embryo normally develops
from the one-cell zygote to the blastocyst stage within the
zona pellucida; however, development in vitro proceeds at
imilar rates in embryos which have had their zonae re-
oved by various means (Sherman, 1978). These observa-
ions suggest that the zona is not critical for developmental
rogression, e.g., by including (or excluding) growth factors.
onetheless, the nonadhesive nature of the zona is likely to
acilitate transport of the developing embryo through the
viduct to the uterus. The development of the trophecto-
erm and, subsequently, trophoblast creates the embryonic
issue responsible for establishing embryonic contact with
he mother. Trophoblast, in particular, are quite effective in
roducing various hormones and cytokines that display
rofound effects on maternal physiology (Petraglia et al.,
998; Roberts et al., 1999). In addition, trophoblast cells
xpress a number of extracellular matrix receptors and
atrix-degrading activities that support interaction with
nd invasion through the endometrium (Cross et al., 1994;
lexander et al., 1996). In situ studies generally indicate
hat the matrix receptors and degrading activities are ex-
ressed in an ordered fashion that correlates well with the
omposition of the associated maternal matrix (Damsky et
l., 1994; Alexander et al., 1996); however, in vitro studies
suggest that embryos display matrix receptors in response
to the matrix, rather than as a result of a rigid program
(Schultz and Armant, 1995).
As discussed in more detail below, studies of delayed
implanting mouse blastocysts have revealed that expres-
sion of certain components of the trophectodermal cell
surface, i.e., EGF2 receptor and perlecan, are very carefully
oordinated with the acquisition of attachment compe-
2 Abbreviations used: Ar, amphiregulin; BTC, b-cellulin; COX-1,
OX-2, cycloxygenase-1 and -2; CSF-1, colony-stimulating factor;
r, epiregulin; E2, estrogen; EGF, epidermal growth factor; HB-EGF, g
Copyright © 2000 by Academic Press. All rightence (Paria et al., 1993; Smith et al., 1997; Tables 1 and 2).
hese studies also indicate that, while normally quite brief,
ven hatched blastocysts can display two functional states
ith regard to attachment competence. Despite the many
tudies demonstrating profound changes in growth factor/
rowth factor receptor or adhesion protein expression dur-
ng peri-implantation stage development in mice, there are
o clear examples of genetic mutations manifest at the
evel of the embryo that result in defects in embryo attach-
ent to the uterine epithelium. Thus, either genes essen-
ial to the embryonic events are novel or there is consider-
ble redundancy of function at this step. The potential roles
f particular embryonically expressed genes and gene prod-
cts are discussed in conjunction with their uterine
omplements in the discussion below.
UTERINE EVENTS
In the mouse, the first discernible sign of implantation is
an increased uterine stromal vascular permeability at the
site of blastocyst apposition (Psychoyos, 1986). This can be
visualized as distinct blue bands along the uterus after an
intravenous injection of a macromolecular blue dye solu-
tion. This increased vascular permeability coincides with
the attachment reaction between the blastocyst and the
uterine luminal epithelium. The attachment reaction oc-
heparin-binding, epidermal growth factor-like growth factor; HS,
heparan sulfate; LIF, leukemia inhibitory factor; LNF-I, lacto-N-
fucopentaose-I; NDF, heregulin/neu differentiating factor; P4, pro-
esterone; PGE2, PGF2a, PGJ2, and PGD2, prostaglandins E2, F2a, J2,
and D2; PGI2, prostacyclin; PPAR, peroxisome proliferator-
activated receptors; RXR, retinoid X receptor; TGF-a, transforming
ABLE 1
arkers of Functional Stages of Mouse Blastocystsa
Marker/functional state Stage I Stage IIb Stage III
Zona 1 2 2
EGF-R 2 2 1
HSPG (perlecan) 2 2 1
Attachment competence 2 2 1
a Three functional stages are proposed: (I) unhatched, attachment
ncompetent, typical of blastocysts encased in zonae pellicidae.
uch blastocysts fail to attach even if zonae are removed by
rtificial means (Sherman, 1978); (II) hatched, incompetent, typical
f blastocysts in implantation delay (Mead, 1993; Paria et al., 1993);
III) hatched, attachment competent. Progression from Stage I to III
s very rapid in vivo. The existence of stage II can be demonstrated
uring implantation delay.
b This normally transient stage can be stabilized in delayed
mplantation models.rowth factor-a; TIMP, tissue inhibitor of metalloproteinase.
s of reproduction in any form reserved.
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219Embryo Implantationcurs in the mouse around midnight on day 4 of pregnancy
(day 1 5 vaginal plug) (Das et al., 1995). This event is
preceded by generalized uterine edema and luminal closure
that lead to close apposition of the blastocyst trophecto-
derm with the luminal epithelium. After the attachment
reaction, epithelial cells undergo apoptosis, while stromal
cells enter into extensive proliferation and differentiation
into decidual cells (decidualization) at the site of blastocyst
apposition (Parr and Parr, 1989). Although incompletely
defined, it is clear that a number of molecular signals render
the uterus receptive and direct the reciprocal interactions
between the blastocyst and the uterus to initiate the pro-
cess of implantation (see below). The temporal and cell-
type-specific expression of these factors and their receptors
in the embryo and uterus during the peri-implantation
period suggests their involvement in different aspects of
embryo development and embryo–uterine interactions dur-
ing implantation (Pollard, 1990).
In the rat (Canivenc et al., 1956), mouse (Yoshinaga and
Adams, 1966), and Mongolian gerbil (Norris and Adams,
1971), both progesterone and estrogen are required for
induction of implantation. In the hamster (Prasad et al.,
1960) and guinea pig (Deanesly, 1960), on the other hand,
only progesterone is required. In the rabbit, both progester-
one and estrogen are required when ovaries are removed in
TABLE 2
Markers of Pre- and Peri-implantation Ut
Note. M, 0800–0900 h; A, 1600–180
period.
a Day 1 represents the day on which the
of expression in pregnant animals. Due to
tion, day 4 has been subdivided into th
afternoon, A, at 1600–1800 h; and night,
amphiregulin; BTC, betacellulin; COX-1
epidermal growth factor; EPI, epiregulin
factor; LIF, leukemia inhibitory factor; M
factor; TGF-a, transforming growth factoearly pregnancy (Pincus and Werthessen, 1938; Chambon,
Copyright © 2000 by Academic Press. All right1949). In the rhesus monkey, some investigators report that
progesterone only can induce implantation (Meyer et al.,
1969), but others claim that removal of estrogen can pre-
vent implantation despite progesterone supplement (Ravin-
dranath and Moudgal, 1988). Although species differences
in steroid requirements for implantation may be explained,
at least in part, by the differences in gene expression in
response to steroids, comparative analysis of the expression
of molecules that play essential roles in implantation is
needed for clarification of the species variation in steroid
requirements for implantation. For example, it is worth
elucidating how the uterus becomes receptive and then
refractory when progesterone alone continuously acts on
the hamster endometrium.
The ability of blastocysts to remain dormant for a pro-
longed period of time creates a unique physiological condi-
tion of delayed implantation (Mead, 1993). Rats and mice
ovulate within 24 h of parturition. When they are mated at
this ovulation and nurse the suckling young, the embryos
conceived at the postpartum ovulation fail to implant after
shedding of the zona pellucida (Lataste, 1891). Implantation
is delayed because the suckling stimulus stimulates high
prolactin secretion that, in turn, suppresses gonadotropin
secretion (Fox and Smith. 1984). The ovaries respond to a
high level of prolactin and low gonadotropin to secrete a
Development in the Mousea
N, 2300–2400 h (attachment reaction)
nal plug is observed. Bars indicate periods
ritical nature in the timing of implanta-
sections (morning, M, at 0800–0900 h;
t 2300–2400 h). Abbreviations used: Ar,
X-2, cyclooxygenases -1 and -2; EGF,
-EGF, heparin-binding, EGF-like growth
, Muc1 mucin; NDF, neu differentiating
a.erine
0 h;
vagi
its c
ree
N, a
, CO
; HB
UC1large amount of progesterone and little estrogen (Yoshinaga
s of reproduction in any form reserved.
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220 Carson et al.et al., 1971). This imbalance of progesterone/estrogen ren-
ers the endometrium nonreceptive to blastocysts despite a
igh level of progesterone secretion because implantation is
ot delayed if suckling stimulus is low. When suckling
timulus subsides, the pituitary gland secretes less prolac-
in and gonadotropin secretion starts to increase. In re-
ponse to this increase the ovaries secrete estrogen. The
ynergistic actions of progesterone and estrogen render the
terus receptive for blastocyst implantation (Yoshinaga,
977). This physiological phenomenon of estrogen/
rogesterone synergism is probably a suitable subject for
olecular analysis of coactivators and corepressors of ste-
oid receptors.
A delay in implantation is also observed in some wild
nimals. In the tammar wallaby, a suckling stimulus main-
ains the blastocyst in a dormant stage; however, cessation
f lactation longer than 72 h alters the endocrine system of
he mother to reactivate the dormant embryo (Renfree,
993). In the spotted skunk, embryonic diapause usually
akes place for approximately 200 days. It has been shown
hat the ovary produces an unidentified substance that is
ssential to stimulate the dormant embryo (Mead, 1989).
ittle attention is being paid to identify this substance.
nvestigation into the mechanisms involved in implanta-
ion in wild animals will broaden our knowledge of the
chemes created to protect and rear the embryo while
dapting to the environment in which these species sur-
ive.
Ovarian steroid hormones are essential for preparation
f the receptive uterus. The major uterine cell types
respond differentially to P4 and/or E2. In the adult mouse, E2
directs proliferation of uterine epithelial cells, while this
process in the stroma requires both P4 and E2 (Pollard,
990). Similar uterine effects occur in the mouse during
arly pregnancy in response to ovarian P4 and E2 (Huet-
udson et al., 1989). On days 1 and 2, preovulatory ovarian
2 stimulates epithelial cell proliferation. On day 3, P4 from
ewly developed corpora lutea induces stromal cell prolif-
ration which is further potentiated by preimplantation
varian E2 secretion on day 4. In contrast, epithelial cells
stop proliferating and become differentiated on day 4. The
uterus becomes receptive to blastocysts on this day and a
“cross-talk” between the blastocyst and the uterus ensures
initiation of implantation. In the rodent, uterine sensitivity
with respect to implantation has been classified into prere-
ceptive, receptive, and nonreceptive (refractory) phases. In
the mouse, the prereceptive uterus on day 3 of pregnancy or
pseudopregnancy becomes receptive on day 4 (the day of
implantation) (Noyes et al., 1963). The receptive uterus
subsequently enters into the nonreceptive phase and fails to
respond to the presence of blastocysts. Similar uterine
events can also be induced in delayed implanting of preg-
nant or pseudopregnant mice. Ovariectomy before the pre-
implantation E2 secretion on the morning of day 4 results in
blastocyst dormancy and inhibition of implantation, a con-
dition termed delayed implantation. This condition can be
maintained by daily P4 treatment which maintains the
Copyright © 2000 by Academic Press. All rightterus at neutral phase (analogous to prereceptive phase)
Paria et al., 1993a). The neutral uterus enters into the
eceptive phase if exposed to E2 after priming with P4.
Treatment with E2 also activates dormant blastocysts in
tero, resulting in the initiation of implantation (Paria et
l., 1993a; Yoshinaga and Adams, 1966). In the absence of
lastocysts, the receptive uterus proceeds to the nonrecep-
ive phase. Thus, the receptive state is defined as the
window” when the uterus is conducive to blastocysts for
mplantation and lasts for a limited period. The mecha-
isms by which E2 activates dormant blastocysts, stimu-
ates uterine receptivity, and initiates implantation are not
learly understood.
Blastocyst’s state of activity determines the window of
mplantation in the receptive uterus. Implantation in the
eceptive uterus has long been considered to occur irrespec-
ive of the blastocyst’s state of activity. Blastocyst transfer
xperiments in delayed implanting of mice have shown that
he blastocyst’s state of activity is also an important deter-
inant in defining the window of implantation in the
eceptive uterus (Paria et al., 1993a). The results of this
nvestigation demonstrated that dormant blastocysts trans-
erred into uteri of P4-treated delayed pseudopregnant re-
cipients implant successfully only if they are transferred
within 1 h of E2 treatment of the recipients. In contrast, day
4 normal or E2-treated in utero-activated blastocysts suc-
essfully implant even when transferred at 16 h after E2
treatment of P4-treated delayed recipients. Dormant blasto-
ysts cultured in vitro acquire “metabolic” activation with
espect to increased oxygen consumption, leading to the
uggestion that the delayed-implanting uterus produces an
nhibitor(s) that renders the blastocysts dormant (McLaren,
973; Weitlauf, 1974). However, a recent investigation
howed that dormant blastocysts cultured in vitro fail to
mplant upon transfer into P4-treated delayed uterus beyond
he critical period of 1 h of E2 treatment (Paria et al., 1993a).
These results suggested the following conclusions. First,
the window of implantation is tightly regulated and opens
when the activated state of the blastocyst coincides with
the receptive state of the uterus. Second, E2 induces very
apidly, but transiently, a factor(s) in the P4-primed uterus
that activates dormant blastocysts in utero for implantation
in the receptive uterus. Finally, although dormant blasto-
cysts acquire metabolic activation in vitro (Weitlauf, 1974),
they do not become implantation competent.
Coordination of differential effects of E2 and catechol-
estrogen on two distinct targets mediates implantation in
mice. Although E2 is essential for blastocyst implantation
n the P4-primed uterus, the mechanism(s) by which E2
initiates this response still remains elusive. It has recently
been demonstrated that the primary ovarian E2 via its
nteraction with nuclear E2 receptors participates in the
reparation of the P4-primed uterus for the receptive state
n an endocrine manner, while its metabolite catecholestro-
en produced from primary E2 in the uterus mediates
blastocyst activation for implantation in a paracrine man-
ner. These results established both that these target-specific
s of reproduction in any form reserved.
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221Embryo Implantationeffects of primary E2 and catecholestrogen are essential for
mplantation and that implantation occurs only when the
ctivated stage of the blastocyst coincides with the recep-
ive state of the uterus (Paria et al., 1998b).
ANIMAL MODELS OF IMPLANTATION
Implantation begins when the blastocyst both assumes a
fixed position in the uterus and establishes a more intimate
relationship with the endometrium. In species in which the
eventual placenta is hemochorial, a series of events must
occur during implantation, i.e., apposition of the blastocyst
to the uterine luminal epithelium, adhesion of trophoblast
to this epithelium, penetration of the epithelium followed
by penetration of the epithelial basal lamina, and stromal
invasion including penetration of the superficial endome-
trial vessels (Schlafke and Enders, 1975). Despite the com-
mon steps and the eventual relationship of trophoblast
bathed with maternal blood, the way in which these stages
are accomplished turns out to be different in different
species. These differences provide opportunities to examine
FIG. 1. Implantation strategies. (A) Murid rodents. Penetration
trophoblast cells, aided by apoptosis of uterine epithelial cells foll
processes of underlying decidual cells. (B) Guinea pig. The syncyt
pellucida, then between uterine epithelial cells, after which the r
uterine stroma. (C) Rabbit. Syncytial trophoblast knobs fuse with o
to penetration into the stroma. (D) Primates. Syncytial trophoblast f
before penetrating the basal lamina. Abbreviations: D, decidual ce
mass; S, stroma; T, trophoblast; ZP, zona pellucida.distinct features of cell interactions (Enders et al., 1995). t
Copyright © 2000 by Academic Press. All rightMurid rodents. Closure of the slot-like uterine lumen
n rodents brings the blastocyst into close apposition to the
uminal epithelium after loss of the zona pellucida (see Parr
nd Parr, 1989). The blastocyst elicits a decidual response
rom the endometrium during the apposition stage of im-
lantation. Subsequently, the epithelium within the pri-
ary decidual area undergoes apoptosis and is phagocytized
y the polytene trophoblast cells of the wall of the blasto-
yst, facilitating epithelial penetration (Fig. 1A). Decidual
ells subsequently penetrate the residual uterine luminal
asal lamina and reorganize the surrounding stroma. The
orming decidua creates a chamber for the blastocyst, ori-
nting it so that the ectoplacental cone region of the
lastocyst is directed toward its eventual mesometrial
osition. Modification of the primary decidua, including its
egeneration, brings blood in contact with the trophoblast
o form the yolk sac placenta and allows space for enlarge-
ent of the conceptus. The removal of the luminal epithe-
ium immediately above the implanting blastocyst and
ven toward the mesometrial end is again accomplished
rior to trophoblast penetration into these areas (Welsh and
nders, 1991). It is not even certain that adhesion between
e uterine epithelium (shaded cells) is accomplished by polytene
by penetration of the residual luminal epithelial basal lamina by
rophoblast of the implantation cone penetrates through the zona
f the blastocyst, including the inner cell mass, is drawn into the
r two uterine epithelial cells creating pegs in the epithelium prior
d near the inner cell mass intrudes between uterine epithelial cells
n, embryonic endoderm; Ep, uterine epithelium; ICM, inner cellof th
owed
ial t
est o
ne o
orme
lls; Erophoblast and the apical surfaces of luminal epithelial
s of reproduction in any form reserved.
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222 Carson et al.cells need be any greater than that involved in normal
phagocytosis of sloughed uterine cells.
The facts that certain rodents (mice and rats) can have
delayed implantation, i.e., the uterine environment con-
trols blastocyst development, and that the blastocyst in-
duces the decidual response prior to epithelial penetration
make these species particularly useful for studying signal-
ing between endometrium and blastocyst (Das et al., 1994b;
Chakraborty et al., 1996; Lim et al., 1999a; Paria et al.,
1999b). The relative ease of finding implantation sites using
markers of local edema also enhances the usefulness of
these species.
Guinea pig. The guinea pig, a caviomorph rodent, has
an implantation pattern quite different from that of the
murid rodents. While the blastocyst is in the uterine lumen,
it develops an implantation cone at the opposite pole from
the inner cell mass. This implantation cone is composed of
syncytial trophoblast and sends processes through the zona
pellucida to adhere to the uterine luminal epithelium
(Enders and Schlafke, 1969). The processes not only pen-
etrate between uterine epithelial cells, but also do not pause
at the uterine basal lamina. Thus, the entire blastocyst
intrudes into the endometrial stroma beneath the luminal
epithelium, losing the zona pellucida in the process (Fig.
1B). Only after the blastocyst is within the endometrium
does the endometrium undergo a decidual response similar
to that of murid rodents. This mechanism of direct invasion
into the endometrium should make the guinea pig a useful
model for epithelial penetration. However, the relatively
long estrous cycle, the fact that only three to five blasto-
cysts are formed, and the great difficulty in detecting the
initial implantation sites make the guinea pig a more
difficult model to use.
Rabbit. The rabbit is an extreme example of blastocyst
adhesion to the apices of epithelial cells in that a large
number of trophoblastic knobs, comprising syncytial tro-
phoblast, first adhere to the apical ends of the epithelial
cells, then fuse with them (Enders and Schlafke, 1971;
Hoffman and Winfrey, 1989). Although such fusion with
the apical ends of cells is not common in other species, it
does indicate that apical–apical cell adhesion can be an
important initiator of implantation (Fig. 1C). The predict-
able ovulation 10 h after mating and the fact that tropho-
blast vesicles can be used to attach to uterine epithelium in
vitro make this an interesting model for the study of apical
cell adhesion (Hoffman et al., 1998). Although trophoblast–
uterine cell fusion may occur in other animals, the rabbit
constitutes the only well-documented example of fusion at
the beginning of the process of epithelial penetration.
Primates. Primate blastocysts implant in a simplex
uterus that has a slot-like lumen. Although the initial
stages of implantation in the human have never been seen,
the orientation of the blastocyst with the inner cell mass
adjacent to the endometrium suggests that in this species,
like other primates studied, the orientation of the blasto-
cyst is brought about by trophoblast near the inner cell
mass adhering to the epithelium (Fig. 1D). In primate b
Copyright © 2000 by Academic Press. All rightspecies in which the early stages have been examined
(macaque, marmoset, baboon), syncytial trophoblast first
forms near the inner cell mass, and in the macaque and
marmoset it can be shown to be the type of trophoblast that
penetrates the uterine epithelium by intruding between
uterine epithelial cells (Enders et al., 1983; Smith et al.,
1987). The stage in which the blastocyst adheres but does
not penetrate the epithelium has yet to be described by
electron microscopy in primates; however, blastocysts
flushed from the baboon uterus at about the time of
implantation show areas of syncytial trophoblast with
cytoplasmic protrusions on their apices (Enders et al.,
1997). Although primate endometrium can be readily stud-
ied in both normal and artificial cycles, it is not practical to
obtain large numbers of early implantation stages in these
species since their fertility is relatively low. Furthermore,
at the present time good methods of ascertaining early
stages of pregnancy with certainty prior to autopsy are not
available.
By about day 12 of pregnancy (3 days after implantation)
the implantation site in the cynomolgus macaque can be
located by ultrasound (Tarantal and Hendrickx, 1988). At
this stage the syncytial trophoblast not only has penetrated
the epithelium, but also has penetrated into maternal blood
vessels, and the lacunar stage of implantation has begun.
This species thus forms a good model for late implantation,
and since cytotrophoblast begins to invade the endometrial
blood vessels at this stage it is also useful to study arterial
invasion and modification by cytotrophoblast (Enders and
Blankenship, 1999). However, the lacunar stage in this
species is not identical to that in the human in that the
human shows more stromal invasion by individual cytotro-
phoblast cells and less vessel invasion at this early stage
(Enders, 1997).
To study trophoblast adhesion to and penetration of the
uterine epithelium, the marmoset should prove particularly
useful (Enders and Lopata, 1999). In this species the blasto-
cyst remains superficial for several days, with masses of
syncytial trophoblast repeatedly invading the epithelium as
the implantation site spreads peripherally. Furthermore
marmosets have one to three blastocysts per pregnancy, the
presence of early pregnancy can be determined with at least
50% accuracy by P4 levels, and the epithelial invasion stage
akes place over several days. Marmoset blastocysts do well
n vitro, and a successful in vitro implantation model has
een established (Lopata et al., 1995). Thus it would be
ossible to compare in vitro and in vivo results and to
anipulate conditions for implantation. Such a model is
articularly important since attempts to use human blasto-
ysts in vitro have not yet provided models comparable to
he in vivo situation.
Domestic animals. The methods of implantation in
omestic animals vary widely. In the pig, implantation
emains superficial, i.e., there is no penetration of the
terine epithelium by trophoblast (Wooding and Flint,
994). Although the trophoblast and luminal epithelium
ecome closely interdigitated and the blood vessels that
s of reproduction in any form reserved.
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223Embryo Implantationdevelop in the blastocyst and those of the uterus indent the
respective epithelia, at no time is the integrity of the
uterine lumen breached. In the sheep, goat, and cow, much
of the placenta remains superficial, but there is an interest-
ing formation of trophoblast binucleate cells which fuse
with uterine luminal epithelial cells, forming transient
heterokaryons in the case of the cow and longer lasting
plaques in the sheep and goat (Wooding, 1992). This is
another example of apical cell adhesion and cell fusion and
has been studied extensively (Wooding et al., 1994). The
gonadotropin-producing trophoblast cells of the horse (en-
dometrial cup cells) are even more intimately associated
with the endometrium than the binucleate cells of ungu-
lates since these cells migrate through the uterine luminal
epithelial cells and into the endometrial stroma (Allen et
al., 1973; Enders and Liu, 1991).
The domestic dog and cat have a central implantation
with many isolated islands or plaques of syncytial tropho-
blast that invade the epithelium by penetrating between
epithelial cells (Leiser and Koob, 1993). Eventually all of the
luminal epithelium in the area where the placental band
will form is eliminated, and after the buildup of more
syncytial and cytotrophoblast the syncytium penetrates the
epithelial basal lamina and surrounds the basal lamina of
the maternal vessels, which subsequently elongate greatly
to form the maternal portion of the placental labyrinth.
These species or another carnivore, the ferret, therefore
could be used to study the way in which syncytial tropho-
blast adheres to and penetrates luminal epithelium since it
has a built-in control of the noninvasive cytotrophoblast
between the numerous areas of invasive syncytial tropho-
blast plaques.
APPOSITION/ATTACHMENT
MODULATORS
Common features of implantation. Depending on the
species, trophoblast penetration of the endometrium may
continue deep into the stroma/decidua (mice, rats, humans)
or remain superficial and not even pass through the lume-
nal epithelium (domestic species). Nonetheless, these im-
plantation strategies all share the interaction of the tro-
phectoderm with the apical surface of the uterine
epithelium. During the conversion to the receptive state,
the uterine epithelium undergoes not only a dramatic
functional, but also a morphological transition. As dis-
cussed in more detail below, the apical glycocalyx decreases
in amount and negative charge character (Schlafke and
Enders, 1975). In addition, normally abundant apical mi-
crovilli gradually retract, creating a flattened surface in
many areas (Schlafke and Enders, 1975; Murphy, 1993).
This process may be related to the observed disruption of
the terminal actin web (Luxford and Murphy, 1989, 1992).
Thie and co-workers (1996, 1997, 1998) have performed a
series of studies using human trophoblast–uterine epithe-
lial adhesion models examining the relationship between c
Copyright © 2000 by Academic Press. All rightttachment and integrity of the cytoskeleton and associated
omponents. These studies have included examination of
he physical forces associated with attachment. The results
ndicate that features of the epithelium associated with the
eceptive phase, i.e., remodeling of tight junctions, adher-
ns junctions, and the actin cytoskeleton, are correlated
ith strong binding between the model cell lines. It should
e noted that the RL95-2 cell line used for many of these
tudies expresses very little MUC1 (Hey and Aplin, 1996). It
ould be of value to generate MUC1-expressing lines of
L95-2 to determine if the lack of mucin, rather than the
ther changes noted, accounted for the increased adhesion
etween these cell lines.
In many species, the receptive phase is strongly associ-
ted with the generation of large apical protrusions believed
o be pinopodes (Given and Enders, 1989; Nikas, 1999). The
unctionality of the pinopode-like structures is not clear. It
s possible that they reflect an important retrieval system
or components in uterine lumenal fluid; however, de-
reased expression of apically disposed catabolic enzymes
ccurs during the receptive phase, suggesting that resorp-
ion may not be a critical function at this time (Classen-
inke et al., 1987). The pinopode-bearing cells might repre-
ent primary sites for embryo interaction since these
tructures physically tower above the rest of the uterine
urface. No molecular characterization of the pinopodes has
een performed. Thus, it is unclear if these structures lack
ntiadhesive components, e.g., mucins, or bear adhesion-
romoting molecules, e.g., integrins and proteoglycans,
roperties that might be expected if these pinopodes func-
ion as embryo attachment sites.
Uterine epithelial cells are highly polarized under most
onditions in vivo or in vitro (reviewed Wegner and Carson,
994). It appears that, in addition to the changes described
bove, alterations in the polarized characteristics of these
ells change during the conversion to the receptive state.
mong these include loss or redistribution of various mark-
rs of apical and basolateral membrane domains (reviewed
n Wegner and Carson, 1994; Denker, 1994). In a number of
pecies, basal processes emerge and penetrate the basal
amina (Denker, 1994, and references within). Denker
1994) also has suggested that these changes reflect aspects
f epithelial–mesenchymal transition and may facilitate
nteractions between the apical poles of the uterine epithe-
ia and trophoblast. Indeed, trophoblast also undergo phe-
otypic changes during implantation giving rise to both
essile and migratory cell populations. These changes in
rophoblast are characterized by multiple changes in inte-
rin and metalloprotease expression reflecting the compo-
ition of the uterine extracellular matrix and the invasive
ehavior of these populations (Damsky et al., 1994; Alex-
nder et al., 1996). Nonetheless, while there are a number of
mpressive changes in the behavior of both uterine epithe-
ium and trophoblast during the implantation process, there
s little evidence to indicate a true epithelial–mesenchymal
onversion for either cell type.
s of reproduction in any form reserved.
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224 Carson et al.Mucins. Apposition and attachment of the embryo to
he endometrium initially involves interactions between
he external surface of the trophectoderm and the apical
urface of the lumenal epithelium of the uterus. Much
nterest is placed on understanding what binding factors or
eceptors support the interactions between these tissues.
onetheless, an equally important principle is that both
he blastocyst and the apical surface of the uterine epithe-
ium are nonadhesive prior to the time of attachment.
herefore, both tissues must be converted to an adhesion-
ompetent state to support these interactions. In the case of
he embryo, the nonadhesive state may be considered
assive in the sense that, for most of the preimplantation
eriod, the embryo is encased in the nonadhesive zona
ellucida; however, the zona is not the only factor in this
egard since zona removal is not sufficient to convert
reimplantation embryos to an adhesive state (see Wegner
nd Carson, 1994). As discussed above, the studies with
elayed implantation models demonstrate that the act of
atching from the zona is distinct from and precedes the
xpression of key attachment-promoting proteins. It is clear
hat as early as the morula stage embryos express cell–cell
dhesion molecules, e.g., E-cadherin, critical for preimplan-
ation development (Riethmacher et al., 1995). Nonethe-
less, these components do not appear to be sufficient to
support attachment to uterine cells in vivo (Noyes et al.,
1963) or extracellular matrix components in vitro (Carson
t al., 1990).
Attachment-competent blastocysts display the ability to
ind to a diverse array of cell types and extracellular matrix
omponents (Carson et al., 1990). Nonetheless, studies by
Noyes et al. (1963) have demonstrated that attachment-
competent rodent blastocysts transferred into uteri prior to
the receptive phase fail to implant. There are likely to be
multiple reasons for this, including inadequate expression
of attachment-promoting molecules. One key factor also
relates to the generalized barrier function that the uterine
mucosa must provide. The uterus and other parts of the
female reproductive tract must provide a barrier to micro-
bial infection, particularly during the mating process. As is
the case in other mucosae, high-molecular-weight mucin
glycoproteins are abundantly expressed at the apical surface
of uterine epithelia under most conditions and provide a
physical barrier to enzymatic attack and infection (Hilkens
et al., 1992). The best studied mucin in reproductive tract
tissues is MUC1 (mouse nomenclature, Muc-1). MUC1
expression is restricted to uterine epithelia and is strongly
influenced by steroid hormones in many species including
mice (Surveyor et al., 1995), pigs (Bowen et al., 1996),
abbits (Hoffman et al., 1998), and baboons (Hild-Petito et
al., 1996). In mice, Muc-1 expression is strongly stimulated
by E2 and repressed by P4 (Surveyor et al., 1995). Moreover,
nti-estrogens and anti-progestins appropriately antagonize
hese steroid hormone actions, suggesting that the activi-
ies are mediated by nuclear steroid hormone receptors.
onetheless, analysis of the mouse Muc-1 promoter does
ot indicate direct regulation by steroid hormone receptors, t
Copyright © 2000 by Academic Press. All rightuggesting that other factors mediate the actions on Muc-1
xpression by uterine epithelia (Zhou et al., 1998). Uterine
xpression of a variety of growth factors and cytokines is
odulated by steroid hormones and may account for the
lterations in Muc-1 expression; however, little informa-
ion is available on what cytokines or growth factors
irectly regulate MUC1 gene expression in any system.
MUC1 has been shown to effectively inhibit cell–cell and
ell–extracellular matrix adhesion (Ligtenberg et al., 1992;
esseling et al., 1995). This property requires a critical
umber of tandem repeats in the extracellular domain and
ppears to reflect steric hindrance to access to cell surface
dhesion-promoting receptors (Wesseling et al., 1996).
imilar results have been obtained with another transmem-
rane mucin, MUC4/sialomucin complex (Komatsu et al.,
997). Although not carefully studied in other systems,
UC4/sialomucin complex is readily detected in rat uter-
ne epithelia in a pattern similar to that observed for Muc-1
n mice and is greatly reduced during the receptive phase
McNeer et al., 1998). A number of other mucin genes have
een identified; however, limited information is available
n their expression in female reproductive tract tissues.
In the context of blastocyst attachment, mucins, in
eneral, and MUC1, in particular, greatly impair access to
he surface of uterine epithelia (DeSouza et al., 1999).
eneral removal or reduction of mucins increases apical
ccess to both enzymatic attack and embryo attachment.
emarkably, while Muc-1 accounts for only about 10% of
he total cell surface mucin complement in mouse uterine
pithelia (Pimental et al., 1996), several lines of evidence
emonstrate that high level expression of MUC1 alone is
ufficient to block embryo attachment (DeSouza et al.,
999). In keeping with these observations, MUC1 expres-
ion is severely reduced in uterine lumenal epithelia during
he receptive phase, enhancing access for blastocyst attach-
ent (Surveyor et al., 1995). In mice, treatment with the
nti-progestin RU486 both restores Muc-1 expression dur-
ng the receptive phase and inhibits implantation (Surveyor
t al., 1995). In contrast, in rabbits and humans MUC1
xpression actually increases during the receptive phase
Hey et al., 1994; Hoffman et al., 1998). Careful examina-
ion of implantation sites in rabbits reveals that MUC1 is
ocally reduced at the site of blastocyst attachment, sug-
esting that embryonic influences trigger reduction of
UC1 expression in this species (Hoffman et al., 1994).
andidate influences would include any factors secreted or
xpressed at the external surface of the trophectoderm that
ight trigger MUC1 down-regulation or activate release
rom the cell surface, e.g., activation of cell surface pro-
eases. In this regard, it has recently been shown that the
DAM, MDC9, is found in uterine epithelia in several
pecies, although MUC1-releasing activity has not been
emonstrated (Olson et al., 1998). It is not clear if local loss
f MUC1 occurs at human implantation sites and it has
een suggested that MUC1 may actually promote embryo
ttachment in humans (Hey et al., 1998). It will be impor-
ant to determine if human blastocysts or products of
s of reproduction in any form reserved.
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225Embryo Implantationhuman blastocysts, e.g., chorionic gonadotropin, can stimu-
late removal of MUC1 to clarify this issue. For ethical
reasons, it is not possible to use human blastocysts to
determine if they can bind to MUC1 directly.
Heparan sulfate (HS) proteoglycans and HS-binding pro-
teins. Heparan sulfate proteoglycans are proteins bearing
one or more high-molecular-weight, linear, highly nega-
tively charged glycosaminoglycan chains of the HS variety.
HS polysaccharides consist of glucosamine units alternat-
ing with either glucuronic or iduronic acid and variously
sulfated on glucosamine and uronic acids. The ordered
nature of the HS chain modification process leads to se-
quences within the polysaccharide, some of which contrib-
ute to a high degree of specific binding to various extracel-
lular matrix proteins and growth factors/cytokines (Taipale
and Keski-Oja, 1997). HS proteoglycans participate in cell
adhesion processes in a variety of systems in which they
appear to promote early stages of these processes (Lyon and
Gallagher, 1998). HS chains are detected at the external
aspect of peri-implantation stage mouse blastocysts and HS
synthesis markedly increases in mouse embryos at the
blastocyst stage (Farach et al., 1987). A number of func-
tional assays indicate that HS participates in early stages of
embryo attachment (Farach et al., 1987, 1988). Similar
studies have been performed using human trophoblastic
and uterine epithelial cell lines, suggesting a similar role for
HS in promotion of adhesion between these cell types
(Rohde and Carson, 1993).
A number of core proteins that carry HS chains have been
identified (David and Bernfield, 1998), but few have been
studied in the context of embryo implantation. Syndecan is
expressed by peri-implantation stage mouse embryos; how-
ever, it appears to be primarily expressed at the interior
aspect of the blastocyst (Sutherland et al., 1991). Thus,
syndecan is not normally located at a site to promote
blastocyst attachment to uterine epithelia. Perlecan is a
large HS proteoglycan typically found in basal lamina of
many tissues and strongly expressed at the human fetal–
maternal interface throughout pregnancy (Rohde et al.,
1998). While perlecan can be detected in mouse embryos at
the two- to four-cell stage (Dziadek et al., 1985), its expres-
sion sharply increases in blastocysts during the transition
to the attachment-competent state and correlates well with
acquisition of attachment competence in vivo, in vitro, and
during activation from implantation delay in vivo (Smith et
al., 1997). These observations are consistent with a role for
perlecan in interactions between blastocysts and uterine
epithelia. Other HS proteoglycans are likely to be involved
as well since recent studies with perlecan null mice do not
indicate implantation defects (Costell et al., 1999; Hassell
et al., 1999). Knockouts have been generated in certain
other HS proteoglycan genes without reported implantation
defects (Xu et al., 1998; Cano-Gauci et al., 1999). Thus,
there may be redundancy in function at this critical step
requiring the generation of multiple null proteoglycan mu-
tants for such studies. In addition, ectopic activation of HS
proteoglycan genes not normally expressed during the peri-
Copyright © 2000 by Academic Press. All rightmplantation period or redistribution to the external blas-
ocyst surface, e.g., syndecans, to support implantation
unction may occur in null contexts, requiring detailed
roteoglycan analyses of such mutants.
While there are a number of HS-binding proteins that
ould mediate interactions between the blastocyst and the
pithelium, only a small subset of HS-binding proteins has
een detected at embryo attachment sites. Perhaps the
ost intriguing example is that of heparin-binding epider-
al growth factor-like growth factor (HB-EGF). HB-EGF
xpression by mouse uterine tissue is highly regulated by
teroid hormones and is essentially lost during the pre-and
eri-implantation period; however, expression is dramati-
ally increased and restricted to implantation sites (Das et
l., 1994b). Interestingly, it is the transmembrane, rather
han the secreted, form of HB-EGF that appears to be
nduced at these sites, suggesting that this protein could
ediate embryo attachment and juxtacrine signaling be-
ween uterine epithelia and trophectoderm. Additional
tudies have demonstrated that HB-EGF binding to blasto-
ysts requires the presence not only of the EGF receptor,
ut also of HS proteoglycan (Raab et al., 1996; Paria et al.,
999b). Consistent with this are observations using a de-
ayed implanting mouse model. HB-EGF expression by
terine epithelia is not induced at implantation sites in this
odel. Conversely, both EGF receptor and HS proteoglycan
perlecan) expression is repressed during delayed implanta-
ion and is restored rapidly upon activation from implanta-
ion delay (Paria et al., 1993; Smith et al., 1997). HB-EGF is
xpressed by uterine epithelia of other species, although the
ssociation of its pattern of expression with implantation is
ot as striking as in the mouse (Kennedy et al., 1994;
irdsall et al., 1996; Yoo et al., 1997). Other HS-binding
roteins have been detected in uterine epithelia of various
pecies during the receptive phase and include amphiregu-
in (Das et al., 1995) and heparin/heparan sulfate-
nteracting protein/L29 (Rohde et al., 1996). In both cases,
xpression is not restricted to implantation sites, but rather
s observed throughout the uterine epithelia. Finally, b3-
and b1-containing integrin complexes have been reported to
bind perlecan, although this appears to be mediated by
interactions with the protein core (Hayashi et al., 1992;
rown et al., 1997). As noted above, expression of av
integrins is greatly enhanced in human uterine epithelia
during the receptive phase.
Carbohydrate ligands and their receptors. Kimber and
colleagues have provided a provocative series of studies
implicating a class of oligosaccharides as mediators of
embryo attachment. The lacto-N-fucopentaose-I (LNF-I)
motif is detected on a subset of cells in mouse uterine
epithelia during the receptive phase and soluble LNF-I
inhibits mouse blastocyst attachment to uterine epithelia
in vitro (Kimber et al., 1988; Lindenberg et al., 1988). In
addition, fluoresceinated LNF-I specifically binds to
attachment-competent mouse embryos (Lindenberg et al.,
1990). The nature of the uterine carriers of LNF-I has not
been determined, but could include both proteins and
s of reproduction in any form reserved.
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226 Carson et al.lipids. Furthermore, the identity of the LNF-I binding sites
on embryos has not been determined. Such binding sites
presumably would fall into the category of mammalian
lectins. Expression of galactose-binding lectins (galectins)
has been examined during early mouse embryogenesis, but
these do not appear to be associated with the sites of
embryo–uterine attachment (see Colnot et al., 1996). Fur-
hermore, various mouse mutants that are null for galectin
enes with no implantation phenotype have been created
see Colnot et al., 1996). Thus, it appears unlikely that
alectins play a critical role in the implantation process.
imilarly, despite multiple efforts by a variety of labs in the
eld, no evidence has been obtained for the presence of
electins at implantation sites. Again, double and triple
ulls have been created for these genes with no apparent
mplantation phenotype (Jung and Ley, 1999). Still, as noted
bove, aspects of implantation strategies may differ among
pecies. MUC1 persists in human uteri during the receptive
hase and at least a subset of MUC1 oligosaccharides can
arry selectin ligands under certain conditions (Hey et al.,
1998). Moreover, preimplantation (four- to eight-cell stage)
human embryos express selectins, although expression ap-
pears to decrease as these embryos approach the blastocyst
stage (Campbell et al., 1995). Nonetheless, it remains
possible that selectins or other mammalian lectins could
participate in aspects of embryo attachment.
Integrins and integrin ligands. There has been increas-
ing interest in integrin cell adhesion molecules in the
reproductive tract and significant data have accumulated to
suggest their involvement in both fertilization and implan-
tation (Bronson and Fusi, 1996; Sueoka et al., 1997). The
integrins are among the best characterized of the immuno-
histochemical markers of uterine receptivity (Lessey, 1998).
These glycoproteins serve as receptors for a variety of
extracellular matrix ligands and act as modulators of cellu-
lar function through both attachment and signal transduc-
tion (Giancotti and Ruoslahti, 1999). The endometrium is
an active site of integrin expression with both constitutive
and cycle-dependent integrin expression (Lessey et al.,
1992, 1994; Tabibzadeh, 1992). Decidualized endometrial
stromal cells also display alteration of integrins at the time
of implantation (Lessey et al., 1994; Ruck et al., 1994). At
least three integrins appear to frame the window of implan-
tation, being coexpressed on glandular epithelium only
during cycle days 20 to 24, the putative window of implan-
tation (Lessey et al., 1992). The apical pole of the luminal
epithelium expresses both avb3 and avb5 (Aplin et al.,
1996). The localization to the apical pole of the luminal
epithelium suggests a role for these integrins in initial
embryo–endometrial interaction (Lessey et al., 1996; Aplin
et al., 1996). Similar findings of apical avb3 and avb5
ntegrin expression have been reported on the epithelial
urface of blastocyst (Campbell et al., 1995; Sutherland et
l., 1993). The placenta also undergoes dramatic program-
atic expression of specific integrins, though this has been
ecently reviewed elsewhere (Damsky et al., 1994; Zhou et
l., 1997).
Copyright © 2000 by Academic Press. All rightThe avb5 and avb3 integrins, along with the a5b1
integrin recognize and bind to the tripeptide sequence
Arg-Gly-Asp (RGD). The RGD sequence has been impli-
cated in trophoblast adhesion to extracellular matrix and
outgrowth (Armant et al., 1986; Yelian et al., 1995), and
peptides containing this sequence can block mouse embryo
attachment to human stromal cells, in vitro (Shiokawa et
al., 1999). Recent studies have shown that implantation in
the mouse can be significantly reduced by intrauterine
injection of RGD peptides and monoclonal antibodies
against the avb3 integrin, though it is not known at present
where the perturbation occurs, on the embryo or endome-
trium (Illera et al., 2000). Integrin expression in the endo-
metrium of other species has now been reported, including
in the pig, baboon, goat, cow, and mouse (Burghardt et al.,
1997; Fazleabas et al., 1997; Guillomot, 1999; Kimmons
and MacLaren, 1999; Simo´n et al, 1998). Interesting differ-
ences in the integrins during the events of pregnancy may
ultimately account for the varied types of attachment and
invasion noted in the implantation process.
The presence of integrins on the surface of the endome-
trium was initially thought to indicate their role as modu-
lators of attachment, based on the receptor-mediated hy-
pothesis of Yoshinaga (1989). Recent and evolving data
using in vitro models of embryo–endometrial interaction
suggest that binding of the embryo may not actually occur
at the apical pole (Bentin-Ley et al., 1999). Rather, the apical
interaction between embryo and maternal surface may be
primarily one of matrix destabilization. Recent data from
invasive melanoma cells, which also express the avb3
ntegrin, show that this integrin can bind to and activate
atrix metalloproteinase 2 (Brooks et al., 1996). Thus,
pical endometrial integrins may function to remove or
igest the extracellular matrix surrounding the embryo and
hereby destabilize the quiescent cellular phenotype. Since
reakdown products of such digestion have been shown to
timulate cell motility (Biannelli et al., 1997), this may
rovide an explanation for the sudden shift from stationary
o invasive cells that occurs at this time. Evidence from the
aboon supports this hypothesis. In this species, avb3
appears 2 weeks later than that observed in the human
(Fazleabas et al., 1997). In this species of primate, invasion
is also delayed relative to that observed in the human.
Trophinin, tastin, and bystin. Functional screening of a
cDNA library derived from a human trophoblastic cell line
has identified several novel proteins with adhesion-
promoting activity. Trophinin is a 61-kDa protein with
eight predicted transmembrane domains and is proposed to
mediate homophilic cell adhesion (Fukuda et al., 1995).
Trophinin is detected at the cell surface in cell lines and in
both normal uterine epithelia and trophectoderm. Thus,
this protein is positioned appropriately to mediate initial
phases of blastocyst–uterine interactions. Trophinin re-
quires the presence of a second cytoplasmic protein, tastin,
to support adhesion; however, these proteins apparently do
not directly interact with each other, but, rather, form part
of a complex with cytoskeletal elements mediated by a
s of reproduction in any form reserved.
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227Embryo Implantationthird protein called bystin (Suzuki et al., 1998). All three
proteins have been detected in both trophoblast and de-
cidual cells at the human fetal–maternal interface as early
as the sixth week of pregnancy with expression declining
toward the end of the first trimester (Suzuki et al., 1999). It
is not clear if these proteins also are localized to implanta-
tion sites in other species. Nonetheless, there is potential
that these novel proteins may mediate early aspects of
embryo–uterine epithelial interactions in humans and pri-
mates.
Metalloproteases and their inhibitors. Many studies
indicate an important role for metalloproteases and their
inhibitors (TIMPs) in regulating aspects of the implantation
process. Dramatic differences in the temporal and spatial
patterns of expression of these molecules are observed both
in uterine tissues and in trophoblast (Fisher and Damsky,
1993; Alexander et al., 1996; Das et al., 1997b). Expression
is strongly influenced by physiologically relevant cytokines
and hormones in both uterine cells (Huang et al., 1998;
Schatz et al., 1999) and trophoblast (Librach et al., 1994;
Meisser et al., 1999). Moreover, metalloprotease inhibitors
administered in vitro or in vivo inhibit extracellular matrix
degradation by trophoblast cells (Fisher et al., 1985;
Behrendtsen et al., 1992; Rechtman et al., 1999) and se-
verely impact formation of decidua (Alexander et al., 1996).
None of these treatments nor any of the null mutations in
metalloproteases or TIMPs have been reported to inhibit
the initial aspects of implantation. Thus, it appears that the
primary role that these activities play in the implantation
process is in decidual tissue remodeling and regulation of
trophoblast invasion. More recently, examination of the
expression and function of disintegrins/ADAMs, cell sur-
face proteins with both adhesion-modulating and proteo-
lytic activities (Blobel, 1997), has revealed provocative
patterns in both uterine (Olson et al., 1998) and trophoblast
(Hurskainen et al., 1999) during the peri-implantation pe-
riod. As null mutations are developed in genes encoding
these proteins, critical assessment of their respective roles
in implantation-related events will be possible.
GROWTH FACTORS, CYTOKINES, LIPID
MESSENGERS, AND THEIR RECEPTORS
The spatiotemporal expression of the EGF family of
growth factors and their receptors (ErbBs) in the peri-
implantation uterus and embryo suggests that these growth
factors serve as local mediators of embryo–uterine interac-
tions during implantation (Das et al., 1997b). The EGF
amily includes EGF itself, transforming growth factor-a
(TGF-a), HB-EGF, amphiregulin (Ar), b-cellulin (BTC), epi-
regulin (Er), heregulins/neu-differentiating factors (NDFs),
and cripto (Cohen, 1962; Derynck et al., 1984; Holmes et
al., 1992; Shing et al., 1993; Shoyab et al., 1988; Toyoda et
al., 1995). These molecules are synthesized as transmem-
brane proteins that are proteolytically processed to release
the mature forms. Both the transmembrane and the mature
Copyright © 2000 by Academic Press. All rightorms are biologically active (Massague and Pandiella,
993). These ligands interact with the receptor tyrosine
inases of the erbB gene family for various signal transduc-
ions. The erbB family constitutes four receptor tyrosine
inases, erbB1, erbB2, erbB3, and erbB4. They share a
ommon structural feature but differ in their ligand speci-
city and kinase activity (Heldin, 1995; Prigent and Le-
oine, 1992; Peles and Yarden, 1993). All members of the
GF family except cripto can interact with erbB family
embers via homodimerization or heterodimerization (re-
iewed in Lim et al., 1997a). Thus, cross-talk between the
receptor subtypes with various ligands can serve as a
potential signaling mechanism.
In mice, TGF-a, HB-EGF, Ar, BTC, Er, and NDF-1 all are
expressed in the uterus at the time of implantation (re-
viewed in Das et al., 1997a). TGF-a is indiscriminately
expressed in the peri-implantation mouse uterus and its
role in implantation is questionable because TGF-a null
mice are apparently fertile (Bruce Mann et al., 1993;
Luetteke et al., 1993); however, it is possible that the
deficiency of TGF-a is compensated by other members of
the EGF family. The Ar gene is induced in the uterine
epithelium throughout day 4 and at the time of blastocyst
attachment. It seems to be a more potent activator of EGF
receptor (ErbB1) in the uterus than that in the blastocyst,
implying a role in intrauterine signaling (Das et al., 1995).
Er, BTC, and NDF-1 are induced in the luminal epithelium
and stroma at the site of implantation (Das et al., 1997a;
Reese et al., 1998). However, the significance of these
growth factors in implantation is not known. HB-EGF with
its expression pattern appears to be highly relevant to the
implantation process (Das et al., 1994b). It is induced solely
in the luminal epithelium surrounding the blastocyst 6–7 h
before the initial attachment of the blastocyst to the uterus.
HB-EGF is not induced at the site of blastocyst during
delayed implantation, but is rapidly induced by the termi-
nation of delayed implantation by E2. This suggests that the
lastocyst signals the luminal epithelial cells to express
B-EGF at the site of subsequent implantation and points
oward a central role for HB-EGF in this process. In vitro
xperiments show that soluble HB-EGF can stimulate blas-
ocyst proliferation, zona hatching, trophoblast outgrowth,
nd tyrosine phosphorylation of ErbB1 in mouse blasto-
ysts. Furthermore, cells expressing the transmembrane
orm of HB-EGF can adhere to active, but not dormant,
lastocysts (Raab et al., 1996). Using growth factor–toxin
onjugates and egfr null blastocysts, it was recently shown
hat HB-EGF can interact with blastocyst ErbB4 and HS
roteoglycan for the initiation of implantation (Paria et al.,
999b). Consistent with the findings in mice, HB-EGF is
xpressed in the human endometrium during the window
f uterine receptivity for implantation (Leach et al., 1999;
oo et al., 1997) and soluble HB-EGF is a potent growth
actor for improving the development of in vitro-fertilized
uman embryos into blastocysts and zona hatching (Martin
t al., 1998).
ErbB1 and ErbB4 are expressed in mouse blastocysts
s of reproduction in any form reserved.
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228 Carson et al.(Paria et al., 1993b, 1999b); however, blastocysts with null
utation for egfr or erbB4 do not manifest obvious defects
uring the initial stage of implantation (Grassman et al.,
995; Threadgill et al., 1995), suggesting that the functions
f these two receptors are redundant. The status of blasto-
ysts with double mutations for egfr and erbB4 is not yet
nown. In addition to HB-EGF, the mouse uterus also
xpresses Er, BTC, and NDF-1 at the site of implantation
hat can interact with ErbB1 and ErbB4 (Lim et al., 1998).
Thus, the contribution of these various ligands to implan-
tation again could be redundant. In general, the expression
of multiple ligands and multiple receptors of the EGF
family might be a protective mechanism to ensure high
probability of embryo development and implantation.
Leukemia inhibitory factor (LIF). Leukemia inhibitory
factor, a pleiotropic cytokine, is expressed at low levels in
many different tissues and exhibits a multitude of biologi-
cal actions including modulation of proliferation and differ-
entiation (Hilton and Gough, 1991). A significant level of
LIF is expressed in the endometrial glands of mice on day 1
(day 1 being the day of observance of the vaginal plug) of
pregnancy and this expression declines by day 3 of gesta-
tion. A second burst of LIF expression occurs in uterine
glands on day 4 of pregnancy, the day of implantation (Bhatt
et al., 1991). On day 5, following implantation, LIF expres-
sion declines and is present at a low level throughout the
rest of pregnancy. A key role for LIF in implantation was
confirmed in a LIF-null mice (Stewart et al., 1992). Ho-
mozygous females lacking a functional LIF gene are viable
and ovulate normally; however, blastocysts fail to implant.
LIF also is expressed in pseudopregnant females, leading to
the suggestion that its expression is under maternal control,
possibly as a direct response to the increase in circulating E2
levels that occurs on days 3–4 of pregnancy (Bhatt et al.,
1991; Shen and Leder, 1992).
In humans, maximal LIF expression is observed during
the P4-dominated secretory phase of the menstrual cycle
Arici et al., 1995; Yang et al., 1996; Cullinan et al., 1996).
IF is expressed at a low level in the glandular epithelial and
tromal cells of proliferative phase endometrium. Glandu-
ar epithelial staining increases significantly in the midse-
retory phase and remains high until the end of the cycle.
ormonal regulation of LIF expression has been investi-
ated in human endometrial stromal and glandular epithe-
ial cells cultured in vitro. These studies indicate that,
hile E2 or P4 fails to enhance LIF expression, various
cytokines and growth factors induce LIF expression in
cultured endometrial cells. These studies suggest that LIF is
not directly regulated by steroid hormones in the human
endometrium (Arici et al., 1995; Senturk and Arici, 1998).
Uterine LIF is proven to be essential for implantation and
HB-EGF is also suspected as an important factor in implan-
tation in the mouse. However, it is not yet known whether
each of these factors acts independently or they work in
concert. Based on published and our unpublished results,
we hypothesize that uterine LIF is important for the prepa-
ration of the uterus and this preparation is required for i
Copyright © 2000 by Academic Press. All rightblastocyst activation and expression of uterine HB-EGF
prior to the attachment reaction. This is consistent with
the preliminary observation of loss of uterine expression of
HB-EGF in LIF(2/2) mice (S. K. Dey et al., unpublished
esults). In turn, HB-EGF may interact with blastocyst HS
roteoglycans and/or ErbBs in a paracrine/juxtacrine man-
er to modulate expression of COX-2 in the stroma at the
ites of blastocyst apposition to initiate the attachment
eaction and decidualization. This is consistent with initial
esults of loss of COX-2 expression in the stroma in the
bsence of HB-EGF expression in LIF(2/2) mice (S. K. Dey
t al., unpublished results). Collectively, the results suggest
hat correct uterine expression of COX-2 is the convergent
ownstream signaling pathway for implantation.
Colony-stimulating factor-1 (CSF-1). CSF-1, a hemato-
oietic growth factor, supports the growth and proliferation
f mononuclear progenitor cells and promotes the prolifera-
ion of mature macrophages (Stanley and Heard, 1977).
nterestingly, it was observed that CSF-1 mRNA and pro-
ein levels were markedly elevated in mouse uterus during
regnancy (Bartocci et al., 1986). In situ hybridization
evealed that CSF-1 was localized exclusively to the lumi-
al and glandular epithelial cells throughout gestation
Arceci et al., 1989). The functional role of this cytokine in
mplantation was studied in the osteopetrotic (op/op)
ouse model. These animals harbor a naturally occurring
ull mutation in the CSF gene and exhibit decreased
mplantation rates and fetal viability (Pollard et al., 1991).
reatment of homozygotes with CSF-1 restored fertility,
ndicating an essential role played by this cytokine during
his process (Wiktor-Jedrzejczak et al., 1991). CSF-1
RNAs also are expressed in human endometrial glands
uring the midproliferative and midsecretory phases of the
enstrual cycle (Pampfer et al., 1991); however, a correla-
ion between abnormal CSF-1 expression and infertility has
ot yet been established.
CSF-1 is the principal growth factor regulating the mac-
ophage population in the uterus. Studies have shown that
he number of uterine macrophages is reduced in CSF-1-less
p/op mice. The macrophages become more rounded in
ppearance compared to those of normal mice (Pollard et
l., 1998). Uterine CSF-1 may therefore be necessary to
aintain normal macrophage population in the uterus
uring early pregnancy. These macrophages may also be
timulated by CSF-1 to produce cytokines that act on the
rophoblast or other lymphoid cells in the uterus producing
omplex autocrine/paracrine loops (Pollard, 1990).
Calcitonin. Calcitonin, a 32-amino-acid peptide hor-
one, has long been known to be synthesized and secreted
rimarily by the parafollicular C cells of the thyroid gland
Austin and Heath, 1981). Its most well-characterized phys-
ological role is to regulate calcium levels in bone and
idney cells. Interestingly, recent studies revealed that
alcitonin is transiently expressed in the rat uterine epithe-
ium overlapping the window of implantation (Ding et al.,
994). In rats, calcitonin mRNA and protein expression
ncreases by day 2 of gestation and reaches a peak on day 4,
s of reproduction in any form reserved.
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229Embryo Implantationthe day before implantation. On day 5, calcitonin expres-
sion starts to decline and by day 6 falls to below detection
limits. P4 is the primary inducer of calcitonin gene expres-
ion in rat endometrium while E2 inhibits P4-mediated
calcitonin gene expression (Ding et al., 1994; Zhu et al.,
1998a). The timing and location of calcitonin synthesis in
the epithelium raise the possibility that calcitonin is se-
creted by the glands into the uterine lumen. Its principal
function may be to regulate blastocyst implantation in an
autocrine or paracrine manner. Recent studies have indeed
shown that the administration of antisense oligode-
oxynucleotides targeted specifically against calcitonin
mRNAs, into the lumen of the preimplantation phase
uterus, results in both suppression of calcitonin gene ex-
pression and a dramatic reduction in the number of im-
planted embryos (Zhu et al., 1998b). Further studies are
necessary to decipher the functional role of calcitonin in
embryo implantation.
The synthesis of calcitonin mRNA and protein also has
been monitored in the human endometrium at different
days of the menstrual cycle (Kumar et al., 1998). Studies
showed that calcitonin expression in human endometrium
is temporally restricted to the epithelium of midsecretory
phase of the cycle, which closely overlaps the putative
window of implantation (Kumar et al., 1998). It also was
observed that, as in rodents, P4 regulates calcitonin expres-
ion in human endometrium. Calcitonin, therefore,
merges as a P4-regulated potential marker of the receptive
human endometrium.
COX-2-derived prostaglandins. Prostaglandins (PGs)
participate in various functions including modulation of
vascular responses, cell proliferation, and differentiation.
PGs are generated via cyclooxygenase (COX), the rate-
limiting enzyme for the conversion of arachidonic acid into
PGH2, the common substrate for various PGs (Smith and
eWitt, 1996). COX exists in two isoforms, COX-1 and
OX-2, encoded by separate genes. Gene targeting in mice
as established distinct functions for these isoforms. While
OX-1-deficient females are fertile with specific parturi-
ion defects, COX-2-deficient females have multiple repro-
uctive failures that include defects in ovulation, fertiliza-
ion, and implantation (Dinchuk et al., 1995; Langenbach et
al., 1995; Lim et al., 1997). The uterine expression of COX-2
in an implantation-specific manner and defective implan-
tation and decidualization in COX-2(2/2) mice establish
that uterine COX-2 is essential for these processes
(Chakraborty et al., 1996; Lim et al., 1997b).
COX is present in both the endoplasmic reticular mem-
rane and the nuclear envelope (Spencer et al., 1998),
uggesting that PGs can exert their effects via different
lasses of receptors. Thus, PGs formed in the endoplasmic
eticulum can exit cells and function via G-protein-coupled
ell surface receptors (Negishi et al., 1995). In the mouse,
ell surface receptors for PGE2, PGF2a, PGD2, and prostacy-
clin (PGI2) are EP, FP, DP, and IP, respectively (Negishi et
al., 1995). Further, EP receptors have four subtypes, EP1,P2, EP3, and EP4, with different signal transductions (Ne-
Copyright © 2000 by Academic Press. All rightgishi et al., 1995). In contrast, PGs produced via nuclear
COX can exert their effects directly on the nucleus by
activating peroxisome proliferator-activated receptors
(PPARs), members of the nuclear hormone receptor super-
family (Mangelsdorf and Evans, 1995). The PPAR family
members are PPARa, PPARg, and PPARd(b) (Kliewer et al.,
1994). PPARa participates in lipid homeostasis and is
activated by hypolipidemic drugs, fatty acids, leukotriene
B4, and PGI2 agonists (Forman et al., 1997; Kliewer et al.,
1997; Motojima et al., 1998). PGI2 agonists, carbaprostacy-
lin and iloprost, also activate PPARd (Forman et al., 1997;
liewer et al., 1997; Lim et al., 1999a). PPARg is primarily
nvolved in adipocyte differentiation and terminal cell
ifferentiation. The antidiabetic thiazolidinedione drugs
nd a metabolite of PGJ2, 15-deoxy-D12,14-PGJ2, act as ligands
for PPARg (Forman et al., 1995, 1997; Kliewer et al., 1997;
Tontonoz et al., 1997). In contrast, information on the
biological roles of PPARd is very limited, although it is
expressed in various embryonic and adult tissues (Braissant
and Wahli, 1998; Braissant et al., 1996). PPARs modulate
transcription by binding to sequence-specific PPAR re-
sponse elements in the promoters of target genes, resulting
in either transcriptional activation or suppression (Muer-
hoff et al., 1992; Tugwood et al., 1992). PPARs heterodimer-
ize with retinoid X receptors (RXRs) for transcriptional
regulation (Kliewer et al., 1992). In the presence of both
PPAR- and RXR-selective ligands, synergistic activation of
target genes occurs (Mukherjee et al., 1997; Schulman et al.,
1998; Lim et al., 1999a).
COX-2-derived PGE2 and/or PGI2 are potential candidates
hat can be involved in implantation working via EP and/or
P receptors. However, IP receptor is not detected in the
terus at the implantation site (Lim et al., 1999a) and
P-deficient mice are fertile (Murata et al., 1997), suggesting
hat IP receptor is not essential for implantation. Although
P receptor subtypes are expressed in the peri-implantation
ouse uterus (Yang et al., 1997), the role of PGE2 acting via
EP1, EP2, and EP3 subtypes in implantation appears to be
insignificant, since mice null for these genes do not show
implantation defects (Ushikubi et al., 1998; Kennedy et al.,
1999). EP4-deficient mice exhibit neonatal lethality and are
thus uninformative for this function (Segi et al., 1998).
Using COX-2(2/2) mice, it has recently been shown that
COX-2-derived PGI2 is the primary PG that is essential for
implantation and decidualization and that the effects of
PGI2 are mediated by its activation of PPARd, demonstrat-
ing the first reported biologic function of this receptor.
However, PGE2 has a complementary role in PGI2-induced
implantation in COX-2-deficient mice (Lim et al., 1999).
SUMMARY AND FUTURE DIRECTIONS
In recent years, there has been a large expansion of
studies of the molecular basis of embryo implantation, not
only in rodents, but also in a number of other species,
including humans. Perhaps not surprising is the diversity of
s of reproduction in any form reserved.
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230 Carson et al.strategies and molecular players implicated in this complex
and crucial biological process. Nonetheless, a focus on
events occurring during the initial interaction of trophec-
toderm and the uterine epithelia and stroma at implanta-
tion sites indicates that some common themes emerge, at
least from the maternal side. Many of these concepts are
summarized based on studies in the mouse in Table 2.
Several patterns emerge. Some uterine factors are strongly
expressed early in the preimplantation period, but are lost
prior to the time of implantation, e.g., MUC-1 and EGF.
Others reappear around the time of implantation in re-
sponse to either hormonal or embryo-derived cues, e.g., LIF,
amphiregulin, cyclooxygenase-2, and HB-EGF. Activation
of some of these genes appears to be transient; however,
some persist and expression may spread from the immedi-
ate implantation site into surrounding decidua, e.g.,
cyclooxygenase-2 and HB-EGF. Expression of several key
markers of the early implantation process has been ex-
tended to other species (Table 3). Loss of MUC1, either
locally or throughout the uterine epithelium, appears to be
a general principle, one potential exception being humans.
Enhanced expression of several other genes in uterine
epithelium has been observed during the receptive phase or
at implantation sites in multiple species. These include
genes encoding growth factors/hormones (HB-EGF, calcito-
nin), enzymes producing lipid hormones (cyclooxygenase-
2), or adhesion-promoting cell surface receptors (avb3 inte-
grins, HB-EGF). As additional work is performed in other
mammals, it will be possible to determine which of these
markers are species-specific or represent well-conserved
responses. Information is also beginning to accumulate on
another class of molecules that appear only in the uterus
during the refractory stage, i.e., if implantation does not
occur. These genes include TNF-a as well as endometrial
leeding-associated factor (ebaf; TGFb4), a human ortho-
ogue of the mouse gene lefty (Kothapalli et al., 1997).
Many questions remain. We still know relatively little
bout the molecular events critical for embryo conversion
ABLE 3
arkers of Uterine Receptivity or Initial Embryo Attachmenta
Marker Rodents Rabbits
MUC1 (mucins) 2 2b
HB-EGF 1 ?
COX-2 1 ?
Calcitonin 1 ?
av, b3 integrins 2 ?
a The presence or absence of the various markers in uterine epi
question mark indicates that information for the corresponding sp
b Only at implantation sites.
c Implantation sites have not been examined.o an attachment-competent state, including what factors
Copyright © 2000 by Academic Press. All rightmbryos secrete that may trigger uterine events. While
nterferon-t is an example of such a factor produced by
any ruminants, it is not clear if similar systems exist in
ther species. In the case of humans and primates, it is
ossible that gonadotropins have direct, early, and, perhaps
ven local actions on uterine cells (Fazleabas et al., 1999).
ipid hormones or even peroxide-based compounds may be
nvolved as well. Mouse mutants undoubtedly will provide
owerful tools to sort out many of these events; however,
hile we have known for over 10 years that LIF-null mice
ave severe implantation defects, we have yet to identify
he downstream events impacted by LIF. Integrating the
ndocrinology, cell, molecular, and developmental biology
o understand the process of embryo implantation will
rovide significant challenges in years to come.
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